LexDanaLexDanabeta
Inventor

Kuo-Pao LAI

Inventor
US

Overview

4→
Patents
2023–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes44%
C07KPeptides33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
PatentTitleYear
12,466,884Tissue-specific WNT signal enhancing molecules and uses202512,297,278Wnt surrogate molecules and uses thereof202511,773,171WNT surrogate molecules and uses thereof202311,642,400Immunogenic/therapeutic glycan compositions and uses thereof2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2025Patents assigned to SURROZEN OPERATING INC (3)· patent assignee history
2023Patents assigned to OBI PHARMA INC (1)· patent assignee history
2023–2025Based in US· patent location history
2023Based in TW· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SURROZEN OPERATING INC32023–2025
OBI PHARMA INC12023
Locations
LocationPatentsSpan
US32023–2025
TW12023